References
- LammersTKiesslingFHenninkWENanotheranostics and image-guided drug delivery: current concepts and future directionsMol Pharm2010761899191220822168
- MahmoudiMSantSWangBSuperparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapyAdv Drug Deliv Rev2011631–2244620685224
- Petri-FinkAChastellainMJuillerat-JeanneretLDevelopment of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cellsBiomaterials200526152685269415585272
- JiaoPFZhouHYChenLXCancer-targeting multifunctionalized gold nanoparticles in imaging and therapyCurr Med Chem201118142086210221517767
- KuijpersSACoimbraMJStormGLiposomes targeting tumour stromal cellsMol Membr Biol201027732834020939769
- van VlerkenLEAmijiMMMulti-functional polymeric nanoparticles for tumour-targeted drug deliveryExpert Opin Drug Deliv20063220521616506948
- XiaoKLuoJFowlerWLA self-assembling nanoparticle for paclitaxel delivery in ovarian cancerBiomaterials200930306006601619660809
- LuoJXiaoKLiYWell-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatmentBioconjug Chem20102171216122420536174
- GurfinkelMKeSWenXNear-infrared fluorescence optical imaging and tomographyDis Markers2003192–310712115096708
- MahmoodUTungCHBogdanovAJrNear-infrared optical imaging of protease activity for tumor detectionRadiology1999213386687010580968
- KeSWenXGurfinkelMNear-infrared optical imaging of epidermal growth factor receptor in breast cancer xenograftsCancer Res200363227870787514633715
- CherrySRMultimodality in vivo imaging systems: twice the power or double the trouble?Annu Rev Biomed Eng20068356216834551
- XiaoKLuoJLiYThe passive targeting of polymeric micelles in various types and sizes of tumor modelsNanosci Nanotechnol Lett201027985
- SparreboomAvan TellingenONooijenWJDetermination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatographyJ Chromatogr19956642383391
- BeijnenJHHuizingMTten Bokkel HuininkWWBioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol)Semin Oncol1994215 Suppl 853627939764
- LiCYuDFInoueTSynthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumorsJ Nucl Med1997387104210479225788
- SparreboomAvan TellingenONooijenWJNonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor ELCancer Res1996569211221158616858
- SparreboomAvan ZuylenLBrouwerECremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implicationsCancer Res19995971454145710197613
- KumarGNWalleUKBhallaKNBinding of Taxol to human plasma, albumin and alpha 1-acid glycoproteinRes Commun Chem Pathol Pharmacol19938033373448102493
- WildMDWalleUKWalleTExtensive and saturable accumulation of paclitaxel by the human plateletCancer Chemother Pharmacol199536141447720174
- van VlerkenLEDuanZLittleSRBiodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer modelMol Pharm20085451652618616278
- WangCWangYWangYCharacterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxelInt J Pharm20114141–225125921596124
- LiYXiaoKLuoJWell-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel deliveryBiomaterials201132276633664521658763
- LiYXiaoWXiaoKWell-defined, reversible boronate crosslinked nanocarriers in response to acidic pH and diol concentrationsAngew Chem Int Ed Engl January 172012 [Epub ahead of print.]